Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot P31751 (AKT2_HUMAN)

Last modified July 22, 2008. Version 89. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (9) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    RAC-beta serine/threonine-protein kinase
    EC=2.7.11.1
Alternative name(s):
    RAC-PK-beta
    Protein kinase Akt-2
    Protein kinase B, beta
      Short name=PKB beta
Gene names
Name: AKT2
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length481 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

General protein kinase capable of phosphorylating several known proteins.

Catalytic activity

ATP + a protein = ADP + a phosphoprotein.

Enzyme regulation

Two specific sites, one in the kinase domain (Thr-309) and the other in the C-terminal regulatory region (Ser-474), need to be phosphorylated for its full activation.

Subunit structure

Interacts (via PH domain) with MTCP1, TCL1A AND TCL1B.

Tissue specificity

In all human cell types so far analyzed.

Involvement in disease

Alterations of AKT2 may contribute to the pathogenesis of ovarian carcinomas.

Sequence similarities

Belongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. RAC subfamily.

Contains 1 AGC-kinase C-terminal domain.

Contains 1 PH domain.

Contains 1 protein kinase domain.

Ontologies

Keywords

   Coding sequence diversityPolymorphism
   LigandATP-binding
Nucleotide-binding
   Molecular functionKinase
Serine/threonine-protein kinase
Transferase
   PTMPhosphoprotein
   Technical term3D-structure

Gene Ontology (GO)

   Biological processprotein modification process Ref.2

Traceable author statement. Source: ProtInc

   Cellular componentcytosol

Inferred from Experiment. Source: Reactome

   Molecular functionprotein binding

Inferred from physical interaction. Source: UniProtKB

protein serine/threonine kinase activity Ref.2

Traceable author statement. Source: ProtInc

Complete GO annotation...

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical view

Molecule processing

Chain1 – 481481RAC-beta serine/threonine-protein kinase

Regions

Domain5 – 108104PH
Domain152 – 409258Protein kinase
Domain410 – 48172AGC-kinase C-terminal
Nucleotide binding158 – 1669ATP By similarity

Sites

Active site2751Proton acceptor By similarity
Binding site1811ATP By similarity

Amino acid modifications

Modified residue3091Phosphothreonine; by PDPK1
Modified residue4741Phosphoserine

Natural variations

Natural variant1881I → V
Natural variant2081R → K

Experimental info

Mutagenesis3091T → E: Constitutively active; when associated with D-474
Mutagenesis4741S → D: Constitutively active; when associated with E-309
Sequence conflict478 – 4814SIRE → FREEKDLLMSLFVSLILFSD FSSLKSHSFSSNFILLSFSS LKK in AAA36585. Ref.1

Secondary structure

................................................................ 481
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
P31751-1 [UniParc].

Last modified November 1, 1995. Version 2.
Checksum: B18C87A7246BFB24

FASTA48155,769
        10         20         30         40         50         60 
MNEVSVIKEG WLHKRGEYIK TWRPRYFLLK SDGSFIGYKE RPEAPDQTLP PLNNFSVAEC 

        70         80         90        100        110        120 
QLMKTERPRP NTFVIRCLQW TTVIERTFHV DSPDEREEWM RAIQMVANSL KQRAPGEDPM 

       130        140        150        160        170        180 
DYKCGSPSDS STTEEMEVAV SKARAKVTMN DFDYLKLLGK GTFGKVILVR EKATGRYYAM 

       190        200        210        220        230        240 
KILRKEVIIA KDEVAHTVTE SRVLQNTRHP FLTALKYAFQ THDRLCFVME YANGGELFFH 

       250        260        270        280        290        300 
LSRERVFTEE RARFYGAEIV SALEYLHSRD VVYRDIKLEN LMLDKDGHIK ITDFGLCKEG 

       310        320        330        340        350        360 
ISDGATMKTF CGTPEYLAPE VLEDNDYGRA VDWWGLGVVM YEMMCGRLPF YNQDHERLFE 

       370        380        390        400        410        420 
LILMEEIRFP RTLSPEAKSL LAGLLKKDPK QRLGGGPSDA KEVMEHRFFL SINWQDVVQK 

       430        440        450        460        470        480 
KLLPPFKPQV TSEVDTRYFD DEFTAQSITI TPPDRYDSLG LLELDQRTHF PQFSYSASIR 


E 

« Hide

References

« Hide 'large scale' references
[1]"Molecular cloning of a second form of rac protein kinase."
Jones P.F., Jakubowicz T., Hemmings B.A.
Cell Regul. 2:1001-1009(1991) [PubMed: 1801921] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Epithelium.
[2]"AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas."
Cheng J.Q., Godwin A.K., Bellacosa A., Taguchi T., Franke T.F., Hamilton T.C., Tsichlis P.N., Testa J.R.
Proc. Natl. Acad. Sci. U.S.A. 89:9267-9271(1992) [PubMed: 1409633] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
[3]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
[4]"NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu)."
Rieder M.J., Livingston R.J., Braun A.C., Montoya M.A., Chung M.-W., Miyamoto K.E., Nguyen C.P., Nguyen D.A., Poel C.L., Robertson P.D., Schackwitz W.S., Sherwood J.K., Witrak L.A., Nickerson D.A.
Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 237-277.
[5]"Activation of protein kinase B beta and gamma isoforms by insulin in vivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro: comparison with protein kinase B alpha."
Walker K.S., Deak M., Paterson A., Hudson K., Cohen P., Alessi D.R.
Biochem. J. 331:299-308(1998) [PubMed: 9512493] [Abstract]
Cited for: CHARACTERIZATION, PHOSPHORYLATION AT THR-309 BY PDPK1.
[6]"The protooncogene TCL1 is an Akt kinase coactivator."
Laine J., Kuenstle G., Obata T., Sha M., Noguchi M.
Mol. Cell 6:395-407(2000) [PubMed: 10983986] [Abstract]
Cited for: INTERACTION WITH MTCP1; TCL1A AND TCL1B.
[7]"Activation of a GST-tagged AKT2/PKBbeta."
Baer K., Lisinski I., Gompert M., Stuhlmann D., Schmolz K., Klein H.W., Al-Hasani H.
Biochim. Biophys. Acta 1725:340-347(2005) [PubMed: 15890450] [Abstract]
Cited for: MUTAGENESIS OF THR-309 AND SER-474, PHOSPHORYLATION AT THR-309 AND SER-474.
[8]"Patterns of somatic mutation in human cancer genomes."
Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. expand/collapse author list , Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.
Nature 446:153-158(2007) [PubMed: 17344846] [Abstract]
Cited for: VARIANTS [LARGE SCALE ANALYSIS] VAL-188 AND LYS-208.
+Additional computationally mapped references.

Cross-references

Sequence databases

M77198 mRNA. Translation: AAA36585.1.
M95936 mRNA. Translation: AAA58364.1.
BC120994 mRNA. Translation: AAI20995.1.
AY708392 Genomic DNA. Translation: AAT97984.1.
PIRA46288.
RefSeqNP_001617.1.
UniGeneHs.631535

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
1GZKX-ray2.30A146-460[»]
1GZNX-ray2.50A146-480[»]
1GZOX-ray2.75A146-460[»]
1MRVX-ray2.80A143-481[»]
1MRYX-ray2.80A143-481[»]
1O6KX-ray1.70A146-481[»]
1O6LX-ray1.60A146-467[»]
1P6SNMR-A1-111[»]
2UW9X-ray2.10A146-477[»]
DisProtDP00304.
ModBaseSearch...

Protein-protein interaction databases

IntActP31751.

PTM databases

PhosphoSiteP31751.

Polymorphism databases

NIEHS-SNPsSearch...

Genome annotation databases

EnsemblENSG00000105221. Homo sapiens. [Contig view]
GeneID208.
KEGGhsa:208.

Organism-specific databases

H-InvDBHIX0015131.
HGNCHGNC:392. AKT2.
HPACAB004204.
MIM164731. gene.
PharmGKBPA24685.
GenAtlasSearch...
GeneCardsSearch...

Phylogenomic databases

HOGENOMP31751.
HOVERGENP31751.

Enzyme and pathway databases

ReactomeREACT_1123. Inhibition of HSL.
REACT_498. Signaling by insulin receptor.

Gene expression databases

ArrayExpressP31751.
CleanExHS_AKT2.
GermOnlineENSG00000105221. Homo sapiens.